Abstract 3913: Inavolisib demonstrates anti-tumorigenic effects in pre-clinical models of serous endometrial cancer.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148808771
Cites:
Cited by:
Related to:
